Streetbeat News

Stock Prices

BTE

GLP

PUMP

SUN

YPF

The article identifies ProPetro Holding (PUMP), YPF (YPF), Global Partners (GLP), Baytex Energy (BTE), and Sunoco (SUN) as notable value stocks in the energy sector based on their low P/E multiples. It highlights their recent earnings per share (EPS) and changes in dividend yields. ProPetro and Global Partners saw a decrease in EPS, while Sunoco reported an increase. YPF's EPS decreased significantly, and Baytex Energy's dividend yield dropped notably.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 2:39 pm

MLGO

Shares of MicroAlgo were halted due to a circuit breaker after experiencing a significant increase, with the stock price surging 56.5%.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 2:39 pm

SVFD

Shares of Save Foods, Inc. were halted due to a circuit breaker after experiencing a significant surge, with the stock price rising by 158.1%.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 2:38 pm

DPZ

Domino's Pizza, during its Investor Day, has projected an annual operating income growth of over 8% for the long-term period from 2024 to 2028. This forecast is a significant indicator of the company's confidence in its future profitability and operational efficiency.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 2:38 pm

FNGS

MSOS

SPY

URNM

The article highlights top-performing ETFs, including SPDR S&P 500 ETF (SPY), Sprott Uranium Miners ETF (URNM), AdvisoryShares Pure US Cannabis ETF (MSOS), and MicroSectors FANG+ ETN (FNGS). SPY is up 20% YTD, while URNM, MSOS, and FNGS have shown significant returns over the last six to twelve months. The article provides technical analysis and potential trading strategies for each ETF, noting the historical performance of stocks in December and the potential for continued gains.

Portfolio Pulse from Cory Mitchell

December 07, 2023 | 2:35 pm

MRK

Merck & Co Inc (NYSE:MRK) reported that its Phase 2 KeyVibe-002 trial for a lung cancer treatment combo did not meet statistical significance. The trial involved vibostolimab/pembrolizumab with or without docetaxel for metastatic NSCLC. Additionally, Merck will discontinue the Phase 3 KEYLYNK-008 trial of Keytruda with Lynparza due to lack of improvement in overall survival. MRK shares dropped 0.76% following the news.

Portfolio Pulse from Vandana Singh

December 07, 2023 | 2:34 pm

COIN

Goldman Sachs analyst Will Nance has maintained a Sell rating on Coinbase Global (NASDAQ:COIN) but increased the price target from $55 to $123.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 2:33 pm

CIEN

Ciena Corp (NYSE:CIEN) exceeded Q4 FY23 revenue and EPS consensus estimates with a 16% Y/Y revenue increase to $1.129 billion and an adjusted EPS of $0.75. Networking Platforms and Global Services segments saw significant growth, but adjusted gross margin declined. The company has $1.25 billion in cash and generated $195.5 million in operating cash flow. Despite positive results, CIEN shares dropped 2.40% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

December 07, 2023 | 2:31 pm

MELI

Over the past 15 years, MercadoLibre (NASDAQ:MELI) has significantly outperformed the market, with an average annual return of 35.16%. A $100 investment in MELI 15 years ago would be worth $10,138.01 today. MercadoLibre's market capitalization currently stands at $79.34 billion.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 2:30 pm

CDW

Over the past decade, CDW (NASDAQ:CDW) has delivered an impressive average annual return of 25.15%, significantly outperforming the market. An investment of $100 in CDW stock 10 years ago would be worth $937.04 today. CDW's market capitalization currently stands at $28.08 billion.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 2:30 pm